1. Home
  2. MNKD vs VYX Comparison

MNKD vs VYX Comparison

Compare MNKD & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • VYX
  • Stock Information
  • Founded
  • MNKD 1991
  • VYX 1881
  • Country
  • MNKD United States
  • VYX United States
  • Employees
  • MNKD N/A
  • VYX N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • VYX
  • Sector
  • MNKD Health Care
  • VYX
  • Exchange
  • MNKD Nasdaq
  • VYX Nasdaq
  • Market Cap
  • MNKD 1.9B
  • VYX 2.1B
  • IPO Year
  • MNKD 2004
  • VYX N/A
  • Fundamental
  • Price
  • MNKD $6.01
  • VYX $13.11
  • Analyst Decision
  • MNKD Buy
  • VYX Strong Buy
  • Analyst Count
  • MNKD 6
  • VYX 7
  • Target Price
  • MNKD $8.92
  • VYX $16.33
  • AVG Volume (30 Days)
  • MNKD 2.7M
  • VYX 1.3M
  • Earning Date
  • MNKD 02-25-2025
  • VYX 02-27-2025
  • Dividend Yield
  • MNKD N/A
  • VYX N/A
  • EPS Growth
  • MNKD N/A
  • VYX N/A
  • EPS
  • MNKD 0.08
  • VYX 4.40
  • Revenue
  • MNKD $267,200,000.00
  • VYX $3,592,000,000.00
  • Revenue This Year
  • MNKD $45.45
  • VYX N/A
  • Revenue Next Year
  • MNKD $16.45
  • VYX N/A
  • P/E Ratio
  • MNKD $75.81
  • VYX $3.01
  • Revenue Growth
  • MNKD 51.35
  • VYX 956.47
  • 52 Week Low
  • MNKD $3.17
  • VYX $10.87
  • 52 Week High
  • MNKD $7.63
  • VYX $15.98
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.75
  • VYX 38.96
  • Support Level
  • MNKD $5.98
  • VYX $12.74
  • Resistance Level
  • MNKD $6.32
  • VYX $13.59
  • Average True Range (ATR)
  • MNKD 0.21
  • VYX 0.44
  • MACD
  • MNKD -0.04
  • VYX -0.07
  • Stochastic Oscillator
  • MNKD 20.55
  • VYX 21.47

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: